Vivo Capital VIII LLC 13D/13G Filings for Passage Bio, Inc. (PASG)

Vivo Capital VIII LLC 13D and 13G filings for Passage Bio, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-12
4:30 pm
Sale
2020-12-31 13G Passage Bio, Inc.
PASG
Vivo Capital VIII LLC 1,487,038
11.000%
-756,459decrease
(-33.72%)
Filing